Drugs that contain Cyclosporine
1. Drug name - CEQUA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10441630 | SUN PHARM | Topical formulations and uses thereof |
Aug, 2033
(10 years from now) | |
| US8980839 | SUN PHARM | Topical aqueous nanomicellar, ophthalmic solutions and uses thereof |
Aug, 2033
(10 years from now) | |
| US9937225 | SUN PHARM | Topical formulations and uses thereof |
Aug, 2033
(10 years from now) | |
| US10918694 | SUN PHARM | Topical cyclosporine-containing formulations and uses thereof |
Feb, 2037
(14 years from now) | |
Treatment: Increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Dosage: SOLUTION;OPHTHALMIC
| Strength | Dosage | Availability |
|---|---|---|
| 0.09% | SOLUTION;OPHTHALMIC | Prescription |
2. Drug name - RESTASIS
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8685930 | ALLERGAN | Methods of providing therapeutic effects using cyclosporin components |
Aug, 2024
(1 year, 10 months from now) | |
| US8648048 | ALLERGAN | Methods of providing therapeutic effects using cyclosporin components |
Aug, 2024
(1 year, 10 months from now) | |
| US8633162 | ALLERGAN | Methods of providing therapeutic effects using cyclosporin components |
Aug, 2024
(1 year, 10 months from now) | |
| US9248191 | ALLERGAN | Methods of providing therapeutic effects using cyclosporin components |
Aug, 2024
(1 year, 10 months from now) | |
| US8642556 | ALLERGAN | Methods of providing therapeutic effects using cyclosporin components |
Aug, 2024
(1 year, 10 months from now) | |
| US8629111 | ALLERGAN | Methods of providing therapeutic effects using cyclosporin components |
Aug, 2024
(1 year, 10 months from now) | |
| US8292129 | ALLERGAN | Dispensing device |
Feb, 2031
(8 years from now) | |
| US8561859 | ALLERGAN | Dispensing device |
Apr, 2032
(9 years from now) | |
| US9676525 | ALLERGAN | Protective cap for a dispenser, and discharge device for discharging pharmaceutical and/or cosmetical liquids |
Feb, 2034
(11 years from now) | |
| US9669974 | ALLERGAN | Protective cap for a dispenser, and discharge device for discharging pharmaceutical and/or cosmetical liquids |
May, 2034
(11 years from now) | |
Treatment: Increase tear production in patients with keratoconjunctivitis sicca (dry eye).; Increase tear production to treat patients with keratoconjunctivitis sicca (dry eye).
Dosage: EMULSION;OPHTHALMIC
| Strength | Dosage | Availability |
|---|---|---|
| 0.05% | EMULSION;OPHTHALMIC | Prescription |
3. Drug name - VERKAZIA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8524779 | SANTEN | Emulsion compositions containing quaternary ammonium compounds |
Jan, 2026
(3 years from now) | |
| US7973081 | SANTEN | Emulsion compositions containing quaternary ammonium compounds |
Jan, 2026
(3 years from now) | |
| US9220694 | SANTEN | Emulsion compositions containing cetalkonium chloride |
Jan, 2026
(3 years from now) | |
| US9956289 | SANTEN | Emulsion compositions containing quaternary ammonium compounds |
Jan, 2026
(3 years from now) | |
| US8298568 | SANTEN | Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
Nov, 2027
(5 years from now) | |
| US9132071 | SANTEN | Compositions containing quaternary ammonium compounds |
Jun, 2029
(6 years from now) | |
Treatment: NA
Dosage: EMULSION;OPHTHALMIC
| Strength | Dosage | Availability |
|---|---|---|
| 0.1% | EMULSION;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.